← Back to Search

VR + Nerve Ablation for Chronic Knee Pain

N/A

Recruiting

Led By Jason Ross, MD

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 minutes before procedure to end of prodedure

Awards & highlights

No Placebo-Only Group

Summary

This trial will look at how using virtual reality along with sedation during watervcooled genicular nerve ablations for chronic knee pain compares to using sedation alone. The study aims to see if

Who is the study for?

This trial is for individuals experiencing chronic knee pain who are undergoing a specific nerve ablation procedure. Participants should be suitable for sedation and the study will explore if adding virtual reality to their treatment can help with pain.

What is being tested?

The study is testing the effectiveness of using a virtual reality headset during genicular nerve ablations versus just sedation alone. It aims to see if VR can better manage pain, improve satisfaction, and enhance function and pain outcomes after one month.

What are the potential side effects?

While not explicitly stated, potential side effects may include discomfort or dizziness from VR use, typical risks associated with sedation, and any standard complications from the nerve ablation procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 minutes before procedure to end of prodedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 minutes before procedure to end of prodedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes before procedure to end of prodedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Procedural related pain

Secondary study objectives

Fentanyl administered

Mean reduction in pain 1 month after procedure

Midazolam administered

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group #1: Virtual Reality HeadsetExperimental Treatment1 Intervention

Group 1 will be assigned to the Virtual Realtity Headset. Participants will wear the headset for at least 10 minutes prior to the planned procedure. Subjects will receive standard procedure. The VR Headset will be removed 10 minutes after the planned procedure.

Group II: Group 2 No Virtual Reality HeadsetActive Control1 Intervention

Group 2 will receive standard care without the use of the Virtuality Reality Headset.

Do I qualify?Apply below to find out